NECTIN4 and benign neoplasm: Nectin-4 was increased in malignant compared to benign lesions. Combined nectin-4 mRNA with CA-125 showed the highest sensitivity in discriminating malignant from benign tumors. Nectin-4 was suggested as a marker for diagnosis and treatment monitoring.